reducing the number of routine vaccines for kids
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
the world's headlines, one feed
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
Hims & Hers is laying the groundwork to offer access to six banned consumer wellness peptides, should the FDA lift restrictions that prevent compounding pharmacies from making them.
Sponsored content brought to you by South Carolina just landed a $1.5 billion investment and more than 1,200 jobs, as Octapharma Plasma relocates its U.S.
[Independent (Kampala)] The Democratic Republic of Congo needs to urgently expand its community-led response to Ebola as new infections and deaths continue to outpace efforts to contain the outbreak…
Epicrispr Biotechnologies has raised $90 million for its Series C round after sharing promising early data around a potential new way to treat a rare muscle disease called facioscapulohumeral muscular…
[Capital FM] Nairobi -- The United States has announced an additional $242 million to support immediate Ebola response, preparedness and humanitarian efforts in countries affected by or at risk from…
[Premium Times] Gavi's US$500 million support will help protect Nigeria's children over the next five years while strengthening the domestic financing that must carry immunisation beyond 2030.